I, GREG O’TOOLE, Assistant Secretary (Acting), Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under subsection 99ADB (6B) of the National Health Act 1953.

Dated        21      December 2015

_____________________________________

GREG O’TOOLE

Assistant Secretary (Acting)

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

1 Name of Determination

 (1) This Determination is the National Health (Originator Brand) Amendment Determination 2015 (No. 2).

(2) This Determination may also be cited as PB 127 of 2015.

2 Commencement

  This Determination commences on 1 January 2016.

3 Amendments to PB 100 of 2015

  Schedule 1 amends the National Health (Originator Brand) Determination 2015 (PB 100 of 2015).

Schedule 1 Amendments

(section 3)

[1] Schedule 1 (after table item 181)

Insert: